Aster Capital Management’s Celldex Therapeutics CLDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-1,446
Closed -$29.7K 1117
2025
Q1
$29.7K Buy
1,446
+1,256
+661% +$25.8K 0.01% 920
2024
Q4
$4.8K Buy
+190
New +$4.8K ﹤0.01% 863